A major breakthrough in cancer research is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This vital malignant inhibitor protein is frequently lost in various forms of tumors, causing https://bookmarkfriend.com/story21991407/mini-antibodies-restore-tumor-suppressor-p53-new-new-pathway-for-malignant-therapy